eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2020
vol. 17
 
Share:
Share:
abstract:
Review paper

Useful assessment of myocardial viability and dyssynchrony from gated perfusion scintigraphy for better qualification for resynchronization therapy. Part 3

Monika Z. Czaja-Ziółkowska
1
,
Jarosław P. Wasilewski
1
,
Jan Głowacki
2, 3
,
Zbigniew Wygoda
4, 5
,
Mariusz Gąsior
1

  1. 3rd Department of Cardiology, School of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
  2. Department of Diagnostic Imaging, Silesian Center for Heart Diseases, Zabrze, Poland
  3. Department of Radiology in Zabrze, Silesian Medical University in Katowice, Poland
  4. Laboratory of Nuclear Medicine, Silesian Center for Heart Diseases, Zabrze, Poland
  5. Institute of Nuclear Medicine and Oncological Endocrinology, Center of Oncology, Gliwice, Poland
Kardiochir Torakochir Pol 2020; 17 (3): 155-159
Online publish date: 2020/09/23
View full text Get citation
 
PlumX metrics:
The first part of the review concerning myocardial imaging by single photon emission computed tomography (SPECT) discussed the basic aspects of interpretation of left ventricular perfusion disorders in stress and rest examination. The second part presented the interpretation of gated SPECT imaging in relation to the assessment of systolic and diastolic left ventricular functions. The third part concerns the assessment of myocardial viability and phase analysis from gated SPECT in the qualification of patients with left ventricular systolic dysfunction for cardiac resynchronization therapy.
keywords:

GATED-SPECT, myocardial viability, phase analysis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.